Product Name:
PKG1-BKCD
Product Number:
ab-nk202-2
Target Full Name: cGMP-dependent protein kinase 1
Target Alias: cGK 1 alpha; cGKI-alpha; cGKI-beta; cGMP-dependent protein kinase 1, alpha isozyme; DKFZp686K042; FLJ36117; KGP1A; Kinase PKG1; PGK; PKG; PKG1-alpha; Protein kinase, cGMP-dependent, type I
Product Type Specific: Protein kinase pan-specific antibody
Antibody Code: NK202-2
Antibody Target Type: Pan-specific
Protein UniProt: Q13976
Protein SigNET: Q13976
Antibody Type: Polyclonal
Antibody Host Species: Rabbit
Antibody Immunogen Source: Human PKG1 (PRKG1) sequence peptide Cat. No.: PE-01BEV99
Antibody Immunogen Sequence: CGGLDDVSNKAYEDAEAKAK
Antibody Immunogen Description: Corresponds to amino acid residues G326 to K344; Just before kinase catalytic domain
Production Method: Corresponds to amino acid residues G326 to K344; Just before kinase catalytic domain
Antibody Modification: Protein kinase pan-specific antibody
Antibody Concentration: 0.34 mg/ml
Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol
Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.
Product Use: Western blotting | Antibody microarray
Antibody Dilution Recommended: 2 µg/ml for immunoblotting
Antibody Species Reactivity: Human
Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 75-77 kDa.
Related Product 1: PKG1-BKCD blocking peptide
Related Product 2: PKG1-pT515+pT517 phosphosite-specific antibody (Cat. No.: AB-PK776)
Related Product 3: PKG1Subtide - PKG1 (PRKG1) protein kinase substrate peptide
Scientific Background: PKG1 (PRKG1) is a protein-serine/threonine kinase of the AGC group and PKG family. It is activated by cGMP, which is generated in response to nitric oxide. Phosphorylation at T59 increases phosphotransferase activity and its affinity for cGMP Phosphorylation at T517 increases phosphotransferase activity. An R177Q mutation in AAT8 results in a constitutively active form of PKG1, which also has reduced cGMP binding.